News
India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...
Eli Lilly has launched Mounjaro in India, a once-weekly injection targeting both type 2 diabetes and obesity, priced at Rs 3,500 for a 2.5mg dose. This dual-action drug stimulates two key hormone ...
Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...
In a nation where the battle against the stomach bulge is as intense as the love for butter parathas, a new player has ...
Eli Lilly has launched Mounjaro (tirzepatide) in India ... But while the buzz is strong, the drug comes with a steep price tag: ₹3,500 for a 2.5 mg vial and ₹4,375 for 5 mg, making long-term use an ...
Amy Schumer has opened up about her current health journey, revealing that she’s seeing strong results using the weight loss drug Mounjaro. In a candid Instagram video filmed from her car ...
Mounjaro is a once-weekly injection available at the starting dose of 2.5 mg. A single-dose vial of 2.5 mg is priced at Rs 3,500, and the the 5 mg injection cost Rs 4,375. Mounjaro is a ...
A WOMAN has joked her partner will have to get used to seeing her bald head, following huge hair loss whilst on Mounjaro. Becky Telfer discovered that she had lost a whopping 39.5 inches off her ...
Pharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs 4,375 for 5 mg, Mounjaro is available by prescription and aims to address ...
However, it is meant to be used alongside a healthy diet and regular workouts. Available as a 2.5 mg vial, Mounjaro will be priced at Rs. 3,500, and the 5 mg vial will be available at Rs 4,375. "This ...
with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide to be marketed as Mounjaro. The medicine will be available in a single-dose vial, meant to be taken as a shot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results